Annual ROE
-290.14%
+63.79%+18.02%
31 December 2023
Summary:
Apellis Pharmaceuticals annual return on equity is currently -290.14%, with the most recent change of +63.79% (+18.02%) on 31 December 2023. During the last 3 years, it has fallen by -1.28% (-0.44%). APLS annual ROE is now -747.12% below its all-time high of -34.25%, reached on 31 December 2017.APLS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-104.65%
+23.07%+18.06%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly return on equity is currently -104.65%, with the most recent change of +23.07% (+18.06%) on 30 September 2024. Over the past year, it has increased by +101.90% (+49.33%). APLS quarterly ROE is now -191.83% below its all-time high of -35.86%, reached on 30 June 2015.APLS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.0% | +49.3% |
| 3 y3 years | -0.4% | +93.4% |
| 5 y5 years | -266.3% | +21.6% |
APLS ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.4% | +21.6% | at high | +93.4% |
| 5 y | 5 years | -266.3% | +67.4% | at high | +93.4% |
| alltime | all time | -747.1% | +67.4% | -191.8% | +93.4% |
Apellis Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -104.65%(-18.1%) |
| June 2024 | - | -127.72%(-11.2%) |
| Mar 2024 | - | -143.79%(-26.3%) |
| Dec 2023 | -290.14%(-18.0%) | -195.18%(-5.5%) |
| Sept 2023 | - | -206.55%(-1.3%) |
| June 2023 | - | -209.36%(+2.2%) |
| Mar 2023 | - | -204.92%(-7.5%) |
| Dec 2022 | -353.93%(-4.4%) | -221.44%(-13.0%) |
| Sept 2022 | - | -254.58%(-36.5%) |
| June 2022 | - | -400.76%(-41.3%) |
| Mar 2022 | - | -682.87%(-53.1%) |
| Dec 2021 | -370.20%(+28.2%) | -1457.39%(-8.5%) |
| Sept 2021 | - | -1593.25%(+213.3%) |
| June 2021 | - | -508.46%(+110.0%) |
| Mar 2021 | - | -242.18%(+40.7%) |
| Dec 2020 | -288.86%(-67.6%) | -172.12%(-49.4%) |
| Sept 2020 | - | -339.93%(+20.1%) |
| June 2020 | - | -283.06%(-1.0%) |
| Mar 2020 | - | -285.84%(+30.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -890.20%(+1023.8%) | -218.57%(+63.7%) |
| Sept 2019 | - | -133.48%(+27.4%) |
| June 2019 | - | -104.81%(+36.0%) |
| Mar 2019 | - | -77.09%(+8.2%) |
| Dec 2018 | -79.21%(+131.3%) | -71.28%(+15.2%) |
| Sept 2018 | - | -61.90%(-5.3%) |
| June 2018 | - | -65.34%(-19.4%) |
| Mar 2018 | - | -81.09%(-1.9%) |
| Dec 2017 | -34.25%(-70.0%) | -82.65%(-58.0%) |
| Sept 2017 | - | -196.85%(+34.4%) |
| June 2017 | - | -146.48%(+52.3%) |
| Mar 2017 | - | -96.16%(+65.4%) |
| Dec 2016 | -114.00%(-14.3%) | -58.13%(+31.8%) |
| Sept 2016 | - | -44.10%(-77.0%) |
| Dec 2015 | -132.99%(+63.0%) | -191.88%(-24.8%) |
| Sept 2015 | - | -255.00%(+611.1%) |
| June 2015 | - | -35.86%(-8.1%) |
| Dec 2014 | -81.58%(-6.9%) | -39.01% |
| Dec 2013 | -87.60% | - |
FAQ
- What is Apellis Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual ROE year-on-year change?
- What is Apellis Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly ROE year-on-year change?
What is Apellis Pharmaceuticals annual return on equity?
The current annual ROE of APLS is -290.14%
What is the all time high annual ROE for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual return on equity is -34.25%
What is Apellis Pharmaceuticals annual ROE year-on-year change?
Over the past year, APLS annual return on equity has changed by +63.79% (+18.02%)
What is Apellis Pharmaceuticals quarterly return on equity?
The current quarterly ROE of APLS is -104.65%
What is the all time high quarterly ROE for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly return on equity is -35.86%
What is Apellis Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, APLS quarterly return on equity has changed by +101.90% (+49.33%)